Do SAFE rounds trigger a 409A valuation requirement?

Not automatically. The rule does not say that signing any SAFE forces a new 409A. The real question is whether the financing provides material new information about the company's value.

A small SAFE on the same terms already reflected in a recent report may not change the conclusion. A large raise, a meaningfully different valuation cap or discount, new investor rights, or financing that changes the company's runway and outlook may make the prior analysis stale.

Remember the sequence: the SAFE itself is not the employee option grant. But if you plan to grant options after the financing, the board needs a reasonable common-stock FMV using all material information available on that later grant date. You cannot ignore the round simply because a SAFE is not priced preferred stock.

Send the appraiser the signed SAFE documents, total amount raised, any side letters, updated cap table, current cash and forecast, and the context around the terms. The appraiser can then decide how much weight the transaction deserves. That is a valuation judgment, not a checkbox.

If the SAFE was already known and included in the prior analysis, do not count it twice. If it is new and material, update before the next grant. When the answer is close, document the materiality review with your appraiser and counsel.

For the general timing rule, read when you need a 409A valuation. For how financing evidence enters the analysis, see the 409A methodology explainer. The separate answer on how a SAFE affects 409A fair market value covers the mechanics without repeating the trigger test. The founder's guide gives the broader material-event framework.